Company intelligence / Profile preview

SPX Capital

Rio de Janeiro, Rio de Janeiro, Brazilspxcapital.com ↗

Ownership: Private
Employees: ~140
Development stage: Other

Overview

SPX Capital is a leading Brazilian investment management firm focused on global macro and alternative asset classes. It manages approximately US$12 billion in assets as of January 2024 and offers strategies in macro, equity, credit, real estate, and private equity. The firm emphasizes long-term returns through robust processes and high-quality human capital. There are no clinical results or drug development activities.

Industry: Investors

Partnerships

Subadviser to Carlyle Group’s $776 million South America buyout fund

Beyond the preview

Go deeper on SPX Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPX Capital.

Explore the full profile